Journal of Immunotherapy
Latest Publications

TOTAL DOCUMENTS

3131
(FIVE YEARS 53)

H-INDEX

91
(FIVE YEARS 0)

Published By Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins

1524-9557
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals Association of Baseline and Pharmacodynamic Biomarkers With Outcomes in Patients Treated With the PD-1 Inhibitor Budigalimab

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Stacie L. Lambert ◽  
Chun Zhang ◽  
Claire Guo ◽  
Tolga Turan ◽  
David L. Masica ◽  
...  
Keyword(s):  
Pharmacodynamic Biomarkers

Pembrolizumab Achieves a Complete Response in an NF-1 Mutated, PD-L1 Positive Malignant Peripheral Nerve Sheath Tumor

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Kristian Larson ◽  
Atlantis Russ ◽  
Hina Arif-Tiwari ◽  
Daruka Mahadevan ◽  
Alex Elliott ◽  
...  
Keyword(s):  
Peripheral Nerve ◽  
Complete Response ◽  
Nerve Sheath Tumor ◽  
Peripheral Nerve Sheath Tumor ◽  
Nerve Sheath

Rapid Unmasking of Immune-related Adverse Events After Discontinuation of Chemotherapy in Chemo-immunotherapy Regimens

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Nicholas D. Riopel ◽  
Quincy Chu ◽  
John Walker ◽  
Carrie Ye
Keyword(s):  
Adverse Events

Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non–small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Martin Sebastian ◽  
Andreas Gröschel ◽  
Sylvia Gütz ◽  
Holger Schulz ◽  
Harald Müller-Huesmann ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
Prior Chemotherapy ◽  
Noninterventional Study

Different Response to Immunotherapy According to Melanoma Histologic Subtype

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Laura Pala ◽  
Fabio Conforti ◽  
Eleonora Pagan ◽  
Vincenzo Bagnardi ◽  
Tommaso M. De Pas ◽  
...  
Keyword(s):  
Histologic Subtype ◽  
Different Response

scholarly journals Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer

2021 ◽  
Vol 45 (1) ◽  
pp. 56-66
Author(s):  
Sumiyuki Nishida ◽  
Soyoko Morimoto ◽  
Yusuke Oji ◽  
Satoshi Morita ◽  
Toshiaki Shirakata ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Immune Responses ◽  
Clinical Outcomes ◽  
Cancer Vaccine ◽  
Advanced Ovarian Cancer ◽  
Hla Class I ◽  
Class I ◽  
Humoral Immune ◽  
Humoral Immune Responses

Preclinical Evaluation of CD64 As a Potential Target For CAR-T-cell Therapy For Acute Myeloid Leukemia

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Xiaolei Sun ◽  
Guoling Wang ◽  
Shiyu Zuo ◽  
Qing Niu ◽  
Xiaoli Chen ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
T Cell ◽  
Cell Therapy ◽  
Myeloid Leukemia ◽  
T Cell Therapy ◽  
Preclinical Evaluation ◽  
Potential Target ◽  
Car T Cell Therapy ◽  
Car T ◽  
Acute Myeloid

In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Markus Freudenreich ◽  
Johanna Tischer ◽  
Tanja Kroell ◽  
Andreas Kremser ◽  
Julia Dreyßig ◽  
...  
Keyword(s):  
Dendritic Cells ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation

TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product Attributes

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Gauri Lamture ◽  
Alan Baer ◽  
Joseph W. Fischer ◽  
Winston Colon-Moran ◽  
Nirjal Bhattarai
Keyword(s):  
T Cell ◽  
Kinase Inhibitor ◽  
Src Family Kinase ◽  
Product Attributes ◽  
Cell Product ◽  
Car T Cell ◽  
Car T
Load More ...
Sign in / Sign up

Export Citation Format

Share Document